Nimenrix is a vaccine that helps protect against meningococcal disease caused by groups A, C, W and Y. Meningococcal disease is a serious bacterial infection that can lead to meningitis and septicaemia.
This vaccine is commonly recommended for adolescents, students, and people travelling to high-risk areas, including those taking part in Hajj or Umrah, as well as individuals with certain medical risk factors.
Vaccination course
-
Single dose injection for most people
-
Provides protection against meningococcal groups A, C, W and Y
Booster doses
-
A booster dose may be recommended every 5 years for people who remain at increased risk or who require ongoing protection for travel or occupational reasons
Your healthcare professional will advise if a booster is needed based on age, risk, and travel plans.